Latest Breaking News On - Eftilagimod alpha in combination with pembrolizumab - Page 1 : comparemela.com

Treatment with eftilagimod alpha plus pembrolizumab resulted in tumor shrinkage and a tolerable safety profile in patients with anti–PD-1/PD-L1–resistant non–small cell lung cancer.

Comunidad autonoma de catalunaI sant pauMargarita majemEuropean lung cancer congressLung cancerHospital de la santa creuSant pauEftilagimod alpha in combination with pembrolizumabPatients with non small cell lung cancerTacti 002 trialHospital de la santa creui sant pau